Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03903731
Other study ID # 16-4049-08B
Secondary ID
Status Completed
Phase
First received
Last updated
Start date July 19, 2018
Est. completion date August 8, 2019

Study information

Verified date November 2020
Source Smith & Nephew, Inc.
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Safety and Performance of Journey II BCS Total Knee System. A Retrospective, Multicenter Study. Patient Reported Outcome Measures.


Recruitment information / eligibility

Status Completed
Enrollment 600
Est. completion date August 8, 2019
Est. primary completion date August 8, 2019
Accepts healthy volunteers No
Gender All
Age group N/A and older
Eligibility Inclusion Criteria: - Subject received primary uni- or bi-lateral total knee arthroplasty with the Journey II BCS Total Knee System for approved indication; - The TKA occurred at least 12 weeks prior to enrollment - Subject records contain Patient Reported Outcome data obtained =3 months prior to as well as =6 months post-enrollment. Exclusion Criteria: - Subject received the JOURNEY II BCS Total Knee System on the affected knee as a revision for a previously failed total or unicondylar knee arthroplasty

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Total knee arthroplasty with Journey II BCS Total Knee System
Journey II BCS Total Knee System

Locations

Country Name City State
Belgium UZ Leuven Leuven
New Zealand Anglesea Clinic Orthopaedics Hamilton
United States Department of Orthopaedics, University of Colorado Denver Aurora Colorado
United States Tennessee Orthopaedic Clinics Knoxville Tennessee
United States Hospital for Special Surgery New York New York

Sponsors (1)

Lead Sponsor Collaborator
Smith & Nephew, Inc.

Countries where clinical trial is conducted

United States,  Belgium,  New Zealand, 

Outcome

Type Measure Description Time frame Safety issue
Primary Revision of one or more study device components We are measuring the number of revision cases Implantation through study completion, approximately 8 years
Secondary Health care utilization: Rehabilitation Number of sessions and duration of rehabilitation in weeks Implantation through study completion, approximately 8 years
Secondary Return to Work Changes in employment status will be recorded with the date on which the change occurred and the change status. Implantation through study completion, approximately 8 years
Secondary Knee Society Score (KSS) Knee Society Score (KSS), a physician- and self-administered questionnaire consisting of several items to measure the outcomes; in this study, the following KOOS scores ranging from 0 to 100 were analyzed: Symptoms Score, Satisfaction Score, Expectation Score, Walking and Standing Score, Standard Activity Score, Advanced Activity Score, Discretionary Activity Score, and Functional Activities Score. Lower KSS scores indicated worse knee conditions. Baseline through last study visit, approximately 8 years
Secondary Visual Analogue Scale (VAS) Visual Analogue Scale (VAS), a self-administered psychometric response instrument to evaluate subject-reported assessment of pain in each knee. There are multiple ways to present VAS scores; in this study, the numerical score ranged from 0 to 100 was used, with the higher score corresponding to the worse pain. Baseline through last study visit, approximately 8 years
Secondary Western Ontario and McMaster Universities Osteoarthritis (WOMAC) Index The Western Ontario and McMaster Universities Osteoarthritis (WOMAC) Index, a self-administered questionnaire consisting of several items (grouped into symptoms, function, daily living, pain, etc) to measure the outcomes using the scores: Total WOMAC score (sum of all scores), WOMAC pain score (range 0 to 20), WOMAC stiffness score (range 0 to 8), and WOMAC physical function score (range of 0 to 68). The higher WOMAC scores corresponded to worse outcomes. Baseline through last study visit, approximately 8 years
Secondary Total Knee Assessment Score Total Knee Assessment score is a self-administered questionnaire comprising multiple-choice questions regarding subjects' knee-related pain and limitations in ability to work, sports, and other daily living activities. In this study, the numbers and percentages of subjects answering each multiple-choice question were summarized. The higher percentage of subjects giving an answer indicating a higher level of limitations was indicative of worse outcomes. Baseline through last study visit, approximately 8 years
Secondary Oxford Knee Assessment (OKS) Oxford Knee Assessment (OKS) is a self-administered questionnaire comprising multiple-choice questions aimed to grade subjects' ability to perform daily activities. The overall score is the sum of all items and range from 0 to 48, with a higher score corresponding to better outcomes. Baseline through last study visit, approximately 8 years
Secondary Knee Injury and Osteoarthritic Outcome Score (KOOS) Knee Injury and Osteoarthritic Outcome Score (KOOS) is a self -administered joint-specific questionnaire comprising questions regarding subject's symptoms, knee stiffness, pain, function and daily living, function and sports and recreational activities, and quality of life; in this study, the following KOOS scores ranging from 0 to 100 (with a score of 0 indicating the worst possible symptoms) were analyzed: Pain Score, Other Symptoms Score, Function in Daily Living Score, Function in Sport and Recreation Score, and Quality of Life Score. Baseline through last study visit, approximately 8 years
Secondary Knee Injury and Osteoarthritic Outcome Score Jr (KOOS Jr) Knee Injury and Osteoarthritic Outcome Score Jr (KOOS Jr) is a shorter self-administered alternative to KOOS focusing on joint pain, stiffness, and daily living and allowing for faster completion by the subject. In this study, the KOOS Interval Score ranging from 0 to 100 was analyzed (with a score of 0 indicating the worst possible symptoms). Baseline through last study visit, approximately 8 years
Secondary SF-12 Version 1 SF-12 Version 1 is a self-administered multipurpose (not aimed to specific disease group) short form survey with questions selected from the longer SF-36 Health Survey and comprising the following scores: Physical Health Composite Score (range 0 for the worst health to 100 for the best health) and Mental Health Composite Score (range 0 for the worst health to 100 for the best health) Baseline through last study visit, approximately 8 years